1 / 9

India Stem Cells Market Research Report

Pharmaion provide latest market research report for "India Stem Cells Market Forecast and Opportunities, 2020". Find quality & high value market research report related to stem cells market in India.

Pharmaion
Download Presentation

India Stem Cells Market Research Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. India Stem Cells Market Forecast&Opportunities,2020 P h a r m a & H e a l t h c a r e C o n s u l t a n t s

  2. I n d u s t r y B r i ef India Stem Cells Market to Grow at 28% through2020 Growing presence of stem cells research centres, increasing consumer awareness and rising medical tourism is driving Indian stem cellsmarket According to recently published Pharmaion report, “India Stem Cells Market Forecast & Opportunities, 2020”, stem cells market in India is anticipated to grow at a CAGR of over 28% over 2015 - 2020. Growth in the market is anticipated on account of increasing investments from the government as well as various private organizations, growing industry focus on stem cell research, and rising awareness about stem cell banking. Moreover, emergence of induced pluripotent stem (iPS) cells as an alternative to embryonic stem cells (ESCs), and evolution of new stem cell therapies are anticipated to boost growth in stem cells market in India over the next fiveyears. Being considered as the “building blocks of life”, stem cells are capable of treating various diseases, such as diabetes, multiple sclerosis, Parkinson's, Alzheimer's, arthritis, blindness, stroke and heart diseases. Moreover, scientists across the country are working on techniques to further enhance the efficacy of stem cell therapy. For instance, menstrual stem cell technology is a budding trend, which is capable of growing heart muscles at a success rate of more than 100 times higher than the 0.2-0.3% for stem cells taken from bone marrow. These cells can revolutionise the way many diseases are being treated and transform the lives of millions of people across the country in the comingyears. On the basis of services offered, India stem cells market has been segmented into two categories, namely, stem cell banking and stem cell research. Stem cell research dominated the market in 2014, and is anticipated to continue its dominance during 2015 - 2020 on account of growing focus on commercialization of public and private research, rising number of stem cell research groups, and escalating cost for traditional drug development. In 2014, adult stem cells accounted for a majority share in the India stem cells market owing to a large number of research being carried out using adult stemcells. “Private stem cell banks are adopting various marketing tactics in order to increase their product visibilityacross the country. Sales force of these private firms are visiting consumers and educating them about stem cell banking concepts and associated advantages. Moreover, in India, the stem cell industry is witnessing increasing level of collaborations among the various stakeholders, which is positively impacting the stem cells market in the country.” said Mr. Karan Chechi, Research Director with Pharmaion, a research based global pharmaceutical and healthcare consultingfirm. 2 ©Pharmaion

  3. Table o f C o n t e n ts 3 ©Pharmaion

  4. Table o f C o n t e n ts 4 ©Pharmaion

  5. Table o f C o n t e n ts 5 ©Pharmaion

  6. R e s e a r c hM e t h o d o l o g y BaselineMethodology: For the study, Pharma ion has gathered information through primary research with respondents in stem cellbanking and research companies across India, followed by external validation of the information by interviewing distributors. We also gathered insights through exhaustive search of credible paid databases and our internal database. Our team of analysts has then prudently evaluated all the collected information and presented it in chronological order to depict a meaningful and comprehensible picture of India stem cells market. While compiling the data, we have also validated all the collected information from multiple sources anddata warehouses, in order to present accurate and precise information of the concerned industry. The same information has then been verified through primary research surveys with competitors to arrive at logical figures. Sources: Company Websites, The National Apex Committee for Stem Cell Research and Therapy (NAC-SCRT), Indian Council of Medical Research (ICMR) and Department of Biotechnology (DBT) 6 ©Pharmaion

  7. S a m p l e D a t a- Snapshot IndiaStemCellsBankingMarketSize,By IndiaStemCellsMarketShare,By Region,ByValue,2010-2020F Value,2010-2020F(USDMillion) 19 23 21 17 15 33.00%33.10%33.20%33.30%33.40%33.50%33.60%33.70%33.80%33.90%34.00% 13 9 South 7 5 3 1 30.00%30.10%30.20%30.30%30.40%30.50%30.60%30.70%30.80%30.90%31.00% West 2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F2020F IndiaSummaryofDiabetesIndicators,2014 28.00%28.10%28.20%28.30%28.40%28.50%28.60%28.70%28.80%28.90%29.00% North 3.00%3.10%3.20%3.30%3.40%3.50%3.60%3.70%3.80%3.90%4.00% Others 2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F AverageCostofStemCellBanking in India(USD) IndiaAdultStemCellsMarket Share,ByType,ByValue,2014 Pancreatic Progenitor Cells,10% Muscle, 10% Retinal, 10% Cardiac,10% Hematopoietic& Bone Marrow, 10% Cancer, 10% Mesenchymal, 10% Neuronal, 10% Limbal,10% Liver, 10% IndiaStemCellsMarketShare,ByService,ByValue,2010-2020F IndiaStemCellsMarketSize,By 60.00%60.10%60.20%60.30%60.40%60.50%60.60%60.70%60.80%60.90%61.00% 23 Value,2010-2020F(USDMillion) 17 21 19 15 13 38.10%38.20%38.30%38.40%38.50%38.60%38.70%38.80%38.90%39.00% 38.00% 9 7 5 3 1 7 2010 2011 2012 20132014 2015E2016F2017F2018F2019F2020F 2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F StemCellBanking Stem CellResearch ©Pharmaion

  8. R e p o r tO r d e r i n g Report Name: India Stem Cells Market Forecast and Opportunities,2020 ReportPrice ToViewSampleORPurchaseReport 8 ©Pharmaion

  9. A b o u t U s & D i s c l a i m er About Us: PharmaionisaresearchbasedmanagementconsultingfirmfocusedexclusivelyonHealthcare&Pharmaceuticalindustry. Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound by legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reports donotjustdeliverdataandknowledgeratherhighlightstheinsights inamoreusableandinteractiveformatforitsclients. Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them with comprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consulting requirements. RelatedReports India Hospitals Market Forecast & Opportunities,2020 Global Tissue Engineered Medical Devices Market Forecast & Opportunities, 2020 Global Cervical Cancer Vaccine Market Forecast & Opportunities, 2020 Disclaimer: The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and first hand.However, Pharmaion Consultants does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internalconsumption.UsageofthesameforpurposeotherthaninternalwillrequirepriorapprovalofPharmaionConsultants. NORTHAMERICA Pharmaion ConsultantsLLC 708 3RD Avenue, 6th Floor, New York, NY, United State, 10017 sales@pharmaion.com +1 646 360 1656 www.pharmaion.com ASIA-PACIFIC Pharmaion Consultants Pvt.Ltd. A – 51, Sector 57, Noida, National CapitalRegion, India - 201301 sales@pharmaion.com +91 - 120 - 4523900 www.pharmaion.com 9 ©Pharmaion

More Related